Screener
Aardvark Therapeutics, Inc. AARD Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Aardvark Therapeutics, Inc.’s reported figures.
The source filing: Aardvark Therapeutics, Inc.’s 10-K, filed March 23, 2026. Open the filing →
- Filed
- Mar 23, 2026, 4:19 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001193125-26-119770
FAQ
- What is Aardvark Therapeutics, Inc.'s free cash flow?
- Aardvark Therapeutics, Inc. (AARD) reported free cash flow of -$16.81M in Q4 2025.
- How has Aardvark Therapeutics, Inc.'s free cash flow changed year-over-year?
- Aardvark Therapeutics, Inc.'s free cash flow decreased by 117.4% year-over-year, from -$7.73M to -$16.81M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Aardvark Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude